HCM
PRTK

Highbridge Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Highbridge Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$108K Sell
2022
Q2 		$310K Sell
2022
Q1 		$603K Buy
2018
Q3 		– Hold
2018
Q2 		– Hold
2017
Q4 		– Sell
2017
Q3 		$5.29M Buy
2017
Q2 		– Sell
2017
Q1 		$749K Buy
2016
Q4 		– Sell
2016
Q3 		$501K Buy